GHA Completes Whole Genome Sequencing Analysis On Saturday’s COVID-19 Case
Another opportunity to tie in pro-vax to variants.
The sequencing test was run on the positive case of COVID-19 confirmed on Saturday. The results have confirmed that this case is from the Kent variant (B.1.1.7), a variant already established in Gibraltar for a number of months. According to a study from Public Health England, two doses of the Pfizer vaccine provides 93% effectiveness against this B.1.1.7 strain.
The GHA’s COVID Laboratory will share these results with the UK genome sequencing consortium based at Cambridge University, contributing to global knowledge of COVID variants and transmission patterns.
Should Gibraltar joining the UK Genome Sequencing Consortium (COG-UK) be a red flag?